Hints and tips:
...A version of this article was first published by Nikkei Asia on January 31. ©2024 Nikkei Inc. All rights reserved....
...Bard specialises in gadgets for vascular treatments....
...Bard, with its lower cost of capital, appears to have spotted a great opportunity....
...The law firm secured a victory for CR Bard, a medical technologies company, after $658m in litigation that had raged for decades with its rival WL Gore & Associates....
...However, it has spent the past three years building its presence in the market for peripheral artery disease, which accounts for 60 per cent of its sales....
International Edition